Samsung Biologics announces 3 trillion won rights offering for expansion
August 28, 2026 | 15:56
Biotechnology provider Samsung Biologics launched a 3 trillion Korean won rights offering to fund long-term manufacturing capacity expansion and broaden its global production portfolio.
Mobile Version